Microchannel Blood Typing Device for Rapid ABO and Rh Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current blood typing methods are inadequate for rapid identification at the point of care, leading to potential harm due to delayed ABO group identification and the administration of universal donor blood, which can cause hemolysis and immune complex formation in non-O group recipients.
Innovation Solution
A portable blood typing device with microchannels, reservoirs, and breakable seals containing specific probes for antigens A, B, and D, allowing for rapid analysis of blood samples to determine ABO and Rh blood types through agglutination reactions, facilitated by a user-friendly design with optional sensors and display for automated results.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional laboratory blood typing methods are used, then accurate ABO group identification is achieved, but the testing time is delayed (20-25 minutes) which is harmful to acutely bleeding patients
Solution Approach 1:
The device segments the blood typing process into separate microchannels, each dedicated to detecting specific blood group antigens (A, B, AB). This segmentation allows parallel processing of multiple antigen detections simultaneously, reducing overall testing time while maintaining accuracy through dedicated detection pathways for each blood group marker
Solution Approach 2:
The patent introduces microspheres coated with specific antibodies as intermediaries between the blood sample and detection system. These antibody-coated microspheres bind to corresponding antigens on red blood cells, enabling rapid visual detection of blood type through agglutination reactions within minutes, thus bridging the gap between traditional lab methods and point-of-care speed requirements
2Productivity
If group O RBCs are administered to all trauma patients as universal donor, then immediate transfusion is provided, but anti-A and anti-B antibodies in the plasma cause RBC hemolysis in non-group O patients (50-55% of population)
Solution Approach 1:
The device performs preliminary blood typing action at the point of care before transfusion is administered. By rapidly determining the patient's ABO blood group type using the microchannel device, clinicians can pre-identify compatible blood types and avoid administering group O RBCs to non-O patients, thereby preventing hemolysis and immune complex formation before they occur
Solution Approach 2:
The system provides immediate feedback on the patient's blood type through visual detection of agglutination patterns in the microchannels. This real-time feedback enables clinicians to adjust transfusion decisions based on actual blood type results rather than relying on universal donor protocols, preventing harmful transfusions while ensuring appropriate blood product administration
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables rapid and accurate identification of blood types within minutes using a small blood sample, reducing the risk of hemolysis and immune complex formation by providing immediate and precise typing, suitable for point-of-care use.
Implementation Method 1
a first probe that binds to antigen A, a second probe that binds to antigen B, and a third probe that binds to antigen D
Implementation Method 2
rapid analysis of blood samples to determine ABO and Rh blood types through agglutination reactions
Data Source
AI summary
The present invention provides point-of-care blood typing devices. The devices require only a small sample of blood and are able to provide results within minutes. The devices are capable of identifying A, B, AB, and O type blood. The devices are also capable of identifying blood that is positive (+) or negative (−) for the D antigen.